New Liquid, Ready-to-Use Tacrolimus Immunoassay to Help Simplify Therapeutic Drug Monitoring

FREMONT, Calif.--Transplant physicians working with clinical laboratories must carefully monitor and manage dosages of immunosuppressant drugs—too low, and the patient may reject a transplanted organ; too high, and toxicity problems arise. To improve monitoring of one of the most commonly prescribed immunosuppressant drugs, tacrolimus, Thermo Fisher Scientific has unveiled the Thermo Scientific QMS Tacroliums Immunoassay, [...]

Accelerated Technology Laboratories, Inc. (ATL) and Institute for Biopharmaceutical Research (IBR, Inc.) Partner to Provide Pipette Calibration Solutions for GLP and GMP Compliant Laboratories

Lauchefeld, Switzerland & West End, NC : Accelerated Technology Laboratories, Inc. (ATL), a leading supplier of Laboratory Information Management Systems (LIMS), is excited to announce a new partnership with Institute for Biopharmaceutical Research (IBR, Inc.) -a leader in turnkey calibration software. ATL is the North American Partner for IBR and will be offering Check&Track v2.0 [...]

Roche unveils intelligent automation management solution at 2013 Clinical Lab Expo

HOUSTON -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced plans today at the AACC 2013 Clinical Lab Expo for the U.S. introduction of the cobas 8100 automated workflow series, an advanced system designed to automate many routine tasks to help diagnostic laboratories increase efficiency, reduce expenses and maximize patient safety. "This total lab automation solution [...]

AD HOC Announcement According to §15 WpHG: QIAGEN to conduct new $100 million share repurchase program

Venlo, The Netherlands, - QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced today that its Managing Board, upon authorization of the Supervisory Board, has passed a resolution to exercise the authorization granted by the General Meeting of Shareholders on June 26, 2013, and to purchase shares in the Company up to a total of [...]

Morpho Detection Appoints Karen Bomba President and CEO

Newark, Calif. - Morpho (Safran), through its subsidiary Morpho Detection, Inc., today announced the appointment of Karen Bomba to President and CEO, effective immediately. Bomba brings more than a decade of executive experience leading Safran companies to the role. Most recently, Bomba served as Chairman and CEO of Labinal, Safran's electrical wiring systems company. Bomba [...]

Bina Accelerates Growth with Fully Subscribed $8M Series B Round, Adds to Executive Team

Redwood City, CA - Bina Technologies, the genomic big data science platform accelerating personalized medicine, today announced that they have added to their Series B financing round with $1.75M in additional funding, bringing their total Series B round to $8M. The additional funding was led by Mohsen Moazami at Columbus Nova Technology Partners (CNTP) and [...]

BioFire Initiates Clinical Study for the FilmArray® Gastrointestinal Panel

SALT LAKE CITY -- BioFire Diagnostics, Inc., recently announced that it has commenced clinical and analytical studies to evaluate the company’s FilmArray Gastrointestinal (GI) Panel, with plans to seek both CE IVD marking and FDA clearance. The comprehensive 23-target panel tests for common bacteria, viruses and protozoa that cause infectious diarrhea. The test is performed [...]

Quanterix to Present Multiple Sessions at AACC Annual Meeting and Clinical Lab Expo

LEXINGTON, Mass. -- Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that they will be attending the AACC Annual Meeting and Clinical Lab Expo on July 28 – August 1, 2013 in Houston, Texas. Quanterix will be presenting research based on its [...]

NanoString Technologies Introduces nCounter Elements™ Reagents to Support Needs of Translational Research and Clinical Laboratory Testing

SEATTLE and HOUSTON – NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an Early Access Program for nCounter Elements™, a line of General Purpose Reagents (GPRs) developed specifically to meet the needs of translational research and clinical laboratories. nCounter Elements GPRs enable researchers [...]

R&D 100 Award Goes to Waters ACQUITY UPC2 System

MILFORD, Mass. -- Waters Corporation (NYSE: WAT) today announced that R&D Magazine recognized the Waters® ACQUITY UPC2™ System as one of "the 100 most technologically significant products introduced into the marketplace over the past year." The ACQUITY UPC2 System is the first in a new class of separations tools based on the technology of UltraPerformance [...]

Access IBO on Knowledge Center